Pneumocystis jirovecii
General medical information for education only, not medical advice. Treatment considerations summarize published guidance at drug-class level; therapy is chosen by the treating clinician using susceptibility results, local resistance patterns and current guidelines.
Overview
A fungus that causes pneumonia in people with weakened immunity (HIV with low CD4 counts, transplant, steroid or chemotherapy treatment).
Infections
Pneumocystis pneumonia (PCP) in people with weakened immunity: HIV with a low CD4 count, organ or stem-cell transplant, cancer treatment, or long-term corticosteroids.
Signs and symptoms
Progressive shortness of breath, dry cough, fever, low oxygen levels.
Antibiotic and antimicrobial resistance
Mutations linked to sulfonamide prophylaxis have been described, with uncertain effect on treatment outcome. Pneumocystis does not respond to standard antifungals such as fluconazole.
Treatment considerations
Trimethoprim-sulfamethoxazole, with corticosteroids for significant hypoxemia; prophylaxis for at-risk patients.

Sources
- CDC. Pneumocystis pneumonia.
- CDC DPDx. Pneumocystis.
Sources accessed November 2026. Links open external sites that InnovexLab does not control.
Medical disclaimer
This page is general educational information summarized from published public-health and professional-society guidance. It is not medical advice, a diagnosis or a treatment recommendation, and reading it does not create a clinician–patient relationship with InnovexLab. Decisions about testing, diagnosis and treatment belong to the treating clinician, using the patient’s history and examination, laboratory and susceptibility results, local resistance patterns and current guidelines. Guidance changes over time; consult the original sources for the latest version. InnovexLab provides this information as is and does not warrant that it is complete or current.
Patients with questions about their health should contact their own healthcare provider. In an emergency, call 911.